Technical Analysis for IMRN - Immuron Limited

Grade Last Price % Change Price Change
grade F 2.56 -6.91% -0.19
IMRN closed down 6.91 percent on Wednesday, August 21, 2019, on 8 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical IMRN trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness -6.91%
Outside Day Range Expansion -6.91%
Wide Bands Range Expansion -6.91%

Older signals for IMRN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Immuron Limited, a microbiome company, focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. It has a technology platform that enables a shorter development therapeutic cycle. The company markets and sells Travelan for the prevention of travellers’ diarrhea. Its lead product candidate IMM-124E is in Phase 2b clinical trials for NASH and ASH. The company also has other preclinical immunotherapy pipeline products targeting immune-related diseases. Immuron Limited has a research and development collaboration agreement with the Walter Reed Army Institute of Research (WRAIR) for the development of a Shigella vaccine; and Naval Medical Research Center for the testing of Travelan in cell lines of campylobacter and enterotoxigenic escherichia coli. The company was founded in 1994 and is based in Blackburn North, Australia.
Medicine Diseases Immunotherapy Microbiology Diarrhea Bacteria Gram Negative Bacteria Immunotherapeutics Immune Related Diseases Tropical Diseases Waterborne Diseases
Is IMRN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 14.29
52 Week Low 2.3843
Average Volume 331,276
200-Day Moving Average 5.7847
50-Day Moving Average 3.1331
20-Day Moving Average 3.1612
10-Day Moving Average 2.946
Average True Range 0.3867
ADX 20.02
+DI 20.1437
-DI 26.2432
Chandelier Exit (Long, 3 ATRs ) 2.7299
Chandelier Exit (Short, 3 ATRs ) 3.6701
Upper Bollinger Band 3.7665
Lower Bollinger Band 2.5559
Percent B (%b) 0.0
BandWidth 38.295584
MACD Line -0.1523
MACD Signal Line -0.0913
MACD Histogram -0.061
Fundamentals Value
Market Cap 8.35 Million
Num Shares 3.26 Million
EPS -2.08
Price-to-Earnings (P/E) Ratio -1.23
Price-to-Sales 14.94
Price-to-Book 3.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.21
Resistance 3 (R3) 3.26 3.10 3.10
Resistance 2 (R2) 3.10 2.94 3.07 3.06
Resistance 1 (R1) 2.83 2.83 2.75 2.78 3.03
Pivot Point 2.67 2.67 2.63 2.64 2.67
Support 1 (S1) 2.40 2.51 2.32 2.35 2.09
Support 2 (S2) 2.24 2.40 2.21 2.06
Support 3 (S3) 1.97 2.24 2.02
Support 4 (S4) 1.92